-
4
-
-
0021194468
-
11C-Ro15-1788, a selective benzodiazepine receptor antagonist
-
11C-Ro15-1788, a selective benzodiazepine receptor antagonist. Acta Pharm. Suecica 21 (1984) 183-188
-
(1984)
Acta Pharm. Suecica
, vol.21
, pp. 183-188
-
-
Ehrin, E.1
Johnstrom, P.2
Stone-Elander, S.3
Nilsson, J.L.4
Persson, A.5
Farde, L.6
Sedvall, G.7
Litton, J.E.8
Eriksson, L.9
Widen, L.10
-
6
-
-
33644857006
-
Neuroprotection by pharmacologic blockade of the GAPDH death cascade
-
Hara M.R., Thomas B., Cascio M.B., Bae B.I., Hester L.D., Dawson V.L., Dawson T.M., Sawa A., and Snyder S.H. Neuroprotection by pharmacologic blockade of the GAPDH death cascade. Proc. Natl. Acad. Sci. USA 103 (2006) 3887-3889
-
(2006)
Proc. Natl. Acad. Sci. USA
, vol.103
, pp. 3887-3889
-
-
Hara, M.R.1
Thomas, B.2
Cascio, M.B.3
Bae, B.I.4
Hester, L.D.5
Dawson, V.L.6
Dawson, T.M.7
Sawa, A.8
Snyder, S.H.9
-
7
-
-
0027419646
-
A new and simple on-line method for the preparation of n.c.a. methyl iodide
-
Holschbach M., and Schüller M. A new and simple on-line method for the preparation of n.c.a. methyl iodide. Appl. Radiat. Isot. 44 (1993) 779-780
-
(1993)
Appl. Radiat. Isot.
, vol.44
, pp. 779-780
-
-
Holschbach, M.1
Schüller, M.2
-
9
-
-
41549084367
-
-
International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH), Q2B: Validation of Analytical Procedures, 1996.
-
International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH), Q2B: Validation of Analytical Procedures, 1996.
-
-
-
-
10
-
-
41549150006
-
-
International Union of Pure and Applied Chemistry, Compendium of Chemical Terminology "The Gold Book", second ed., 1997. McNaught, A.D., Wilkinson, A. (Eds.) [ISBN 0-8-654-26848]. 〈http://www.chem.qmul.ac.uk/iupac/bibliog/gold.html〉.
-
International Union of Pure and Applied Chemistry, Compendium of Chemical Terminology "The Gold Book", second ed., 1997. McNaught, A.D., Wilkinson, A. (Eds.) [ISBN 0-8-654-26848]. 〈http://www.chem.qmul.ac.uk/iupac/bibliog/gold.html〉.
-
-
-
-
12
-
-
0344146472
-
11C]methyl triflate
-
11C]methyl triflate. J. Label. Compd. Radiopharm. 42 (1999) 1183-1193
-
(1999)
J. Label. Compd. Radiopharm.
, vol.42
, pp. 1183-1193
-
-
Langer, O.1
Någren, K.2
Dollé, F.3
Lundkvist, C.4
Sandell, J.5
Swahn, C.G.6
Vaufrey, F.7
Crouzel, C.8
Mazière, B.9
Halldin, C.10
-
16
-
-
0021718239
-
11C]methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate (RO 15.1788-11C): a specific radioligand for the in vivo study of central benzodiazepine receptors by positron emission tomography
-
11C]methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate (RO 15.1788-11C): a specific radioligand for the in vivo study of central benzodiazepine receptors by positron emission tomography. Int. J. Appl. Radiat. Isot. 35 (1984) 973-976
-
(1984)
Int. J. Appl. Radiat. Isot.
, vol.35
, pp. 973-976
-
-
Mazière, M.1
Hantraye, P.2
Prenant, C.3
Sastre, J.4
Comar, D.5
-
17
-
-
33748114022
-
Phase II/III controlled trial of TCH 346 in patients with amyotrophic lateral sclerosis
-
Miller R.G., Bradley W., Cudkowicz M., Meininger V., Mitsumoto H., Sauer D., Silani V., Strong M., Swash M., and Vernotica E. Phase II/III controlled trial of TCH 346 in patients with amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 6 Suppl. 1 (2005) 13-16
-
(2005)
Amyotroph. Lateral Scler.
, vol.6
, Issue.SUPPL. 1
, pp. 13-16
-
-
Miller, R.G.1
Bradley, W.2
Cudkowicz, M.3
Meininger, V.4
Mitsumoto, H.5
Sauer, D.6
Silani, V.7
Strong, M.8
Swash, M.9
Vernotica, E.10
-
18
-
-
0038397143
-
11C]Ro15-4513 and its application in an extremely low concentration region to an ARG study
-
11C]Ro15-4513 and its application in an extremely low concentration region to an ARG study. Nucl. Med. Biol. 30 (2003) 335-343
-
(2003)
Nucl. Med. Biol.
, vol.30
, pp. 335-343
-
-
Noguchi, J.1
Suzuki, K.2
-
19
-
-
33750719088
-
TCH346 as a neuroprotective drug in Parkinson's disease: a double-blind, randomised, controlled trial
-
Olanow C., Schapira A., LeWitt P., Kieburtz K., Sauer D., Olivieri G., Pohlmann H., and Hubble J. TCH346 as a neuroprotective drug in Parkinson's disease: a double-blind, randomised, controlled trial. Lancet Neurol. 5 (2006) 1013-1020
-
(2006)
Lancet Neurol.
, vol.5
, pp. 1013-1020
-
-
Olanow, C.1
Schapira, A.2
LeWitt, P.3
Kieburtz, K.4
Sauer, D.5
Olivieri, G.6
Pohlmann, H.7
Hubble, J.8
-
20
-
-
41549125126
-
-
Qaim, S.M., Clark, J.C., Crouzel, C., Guillaume, M., Helmeke, H.J., Nebeling, B., Pike, V.W., Stöcklin, G., 1993. PET radionuclide production. In: Radiopharmaceuticals for PET. Kluwer Academic Publishers, Dordrecht, pp. 15-26.
-
Qaim, S.M., Clark, J.C., Crouzel, C., Guillaume, M., Helmeke, H.J., Nebeling, B., Pike, V.W., Stöcklin, G., 1993. PET radionuclide production. In: Radiopharmaceuticals for PET. Kluwer Academic Publishers, Dordrecht, pp. 15-26.
-
-
-
-
22
-
-
0033830739
-
2 gas target: effect of irradiation dose, irradiation history, oxygen content and beam energy
-
2 gas target: effect of irradiation dose, irradiation history, oxygen content and beam energy. Radiochim. Acta 88 (2000) 211-215
-
(2000)
Radiochim. Acta
, vol.88
, pp. 211-215
-
-
Suzuki, K.1
Yamazaki, T.2
Sasaki, M.3
Kubodera, A.4
|